Overview
IXJ market data
Price History
IXJ price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for IXJ. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?The Motley Fool · Jul 23, 2026, 8:15 PM
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?The Motley Fool · Jul 21, 2026, 7:31 PM
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?The Motley Fool · Jul 21, 2026, 6:30 PM
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?The Motley Fool · Jul 20, 2026, 3:15 PM
Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETFThe Motley Fool · Jul 16, 2026, 2:15 PM
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?The Motley Fool · Jun 26, 2026, 12:15 PM
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.The Motley Fool · May 27, 2026, 4:15 PM
From Shingles To Superbugs: Eli Lilly Expands Infectious Disease Push In Billion-Dollar Buying WaveBenzinga · May 26, 2026, 5:38 PM
White House Reportedly Preparing To Oust FDA Commissioner Marty MakaryBenzinga · May 11, 2026, 2:45 PM